Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.
- DOI
- 10.1001/jamaoncol.2019.4636
- Published
- 2020 Feb 1
- Container
- JAMA oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaoncol.2019.4636,
title = {Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.},
author = {Armstrong AJ and Al-Adhami M and Lin P and Parli T and Sugg J and Steinberg J and Tombal B and Sternberg CN and de Bono J and Scher HI and Beer TM},
year = {2020},
journal = {JAMA oncology},
doi = {10.1001/jamaoncol.2019.4636},
url = {https://doi.org/10.1001/jamaoncol.2019.4636}
}RIS
TY - JOUR TI - Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials. AU - Armstrong AJ AU - Al-Adhami M AU - Lin P AU - Parli T AU - Sugg J AU - Steinberg J AU - Tombal B AU - Sternberg CN AU - de Bono J AU - Scher HI AU - Beer TM PY - 2020 JO - JAMA oncology DO - 10.1001/jamaoncol.2019.4636 UR - https://doi.org/10.1001/jamaoncol.2019.4636 ER -
APA
AJ, A., M, A., P, L., T, P., J, S., J, S., B, T., CN, S., J, D. B., HI, S., & TM, B. (2020). Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2019.4636
Source records
- pubmed · retrieved 2026-09-26T22:37:43.219Z
- europe-pmc · retrieved 2026-09-26T22:37:43.232Z